Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 207

    1.

    A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone.

    Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, Haskins K.

    Diabetes. 2002 Feb;51(2):347-55.PMID: 11812741 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

    Chong MM, Chen Y, Darwiche R, Dudek NL, Irawaty W, Santamaria P, Allison J, Kay TW, Thomas HE.

    J Immunol. 2004 May 1;172(9):5714-21.PMID: 15100317 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.

    Suk K, Kim S, Kim YH, Kim KA, Chang I, Yagita H, Shong M, Lee MS.

    J Immunol. 2001 Apr 1;166(7):4481-9.PMID: 11254704 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Nondepleting anti-CD4 has an immediate action on diabetogenic effector cells, halting their destruction of pancreatic beta cells.

    Phillips JM, Harach SZ, Parish NM, Fehervari Z, Haskins K, Cooke A.

    J Immunol. 2000 Aug 15;165(4):1949-55.PMID: 10925277 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

    Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL.

    J Immunol. 2001 Jul 15;167(2):1081-9.PMID: 11441119 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.

    Kim S, Kim HS, Chung KW, Oh SH, Yun JW, Im SH, Lee MK, Kim KW, Lee MS.

    Diabetes. 2007 Oct;56(10):2561-8. Epub 2007 Jul 9.PMID: 17620422 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.

    Calderon B, Suri A, Pan XO, Mills JC, Unanue ER.

    J Immunol. 2008 Nov 15;181(10):6964-74.PMID: 18981116 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

    Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P.

    J Clin Invest. 2000 Feb;105(4):459-68.PMID: 10683375 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.

    Peterson JD, Haskins K.

    Diabetes. 1996 Mar;45(3):328-36.PMID: 8593938 [PubMed - indexed for MEDLINE]Related articles

    12.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    13.

    Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.

    Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E.

    Biochem Biophys Res Commun. 2003 May 2;304(2):378-84.PMID: 12711326 [PubMed - indexed for MEDLINE]Related articles

    14.

    Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.

    Mathews CE, Graser RT, Savinov A, Serreze DV, Leiter EH.

    Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):235-40.PMID: 11136257 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

    Kim SK, Tarbell KV, Sanna M, Vadeboncoeur M, Warganich T, Lee M, Davis M, McDevitt HO.

    Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14204-9. Epub 2004 Sep 20.PMID: 15381770 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.

    Qin HY, Chaturvedi P, Singh B.

    Int Immunol. 2004 Dec;16(12):1723-32. Epub 2004 Oct 18.PMID: 15492021 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

    Daniel D, Gill RG, Schloot N, Wegmann D.

    Eur J Immunol. 1995 Apr;25(4):1056-62.PMID: 7537670 [PubMed - indexed for MEDLINE]Related articles

    18.

    Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.

    Serreze DV, Pierce MA, Post CM, Chapman HD, Savage H, Bronson RT, Rothman PB, Cox GA.

    J Immunol. 2003 Mar 1;170(5):2742-9.PMID: 12594305 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells.

    Horio F, Fukuda M, Katoh H, Petruzzelli M, Yano N, Rittershaus C, Bonner-Weir S, Hattori M.

    Diabetologia. 1994 Jan;37(1):22-31.PMID: 8150225 [PubMed - indexed for MEDLINE]Related articles

    20.

    Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB.

    Stephens LA, Thomas HE, Kay TW.

    J Autoimmun. 1997 Jun;10(3):293-8.PMID: 9218757 [PubMed - indexed for MEDLINE]Related articles